Founder of one of the largest publicly listed pharma companies is now India's 20th richest person

This company is Saurabh Mukherjee's favourite Pharma stock

According to Forbes, Murli K Divi, founder of Divi's Laboratories Ltd is India's 20th richest person. He has a net worth of Rs 51,887 crore as of August 30, 2022. 

He has a postgraduate degree in Pharmaceutical Chemistry from Manipal College of Pharmacy. Murli is currently the company's Managing Director (MD). 

Divi's Laboratories Limited has a market capitalisation of Rs 95197 crore. It is one of the world's largest pharmaceutical companies, producing Active Pharmaceutical Ingredients (APIs), Intermediates, and Nutraceuticals. It operates two manufacturing plants, one in Visakhapatnam and one in Hyderabad. 

The company has a significant international presence. Exports account for approximately 88 per cent of the company's revenue. The company's core competency is custom synthesis in contract manufacturing of APIs. Among its clients are Pfizer, Merck, and GSK. 

Regarding the company's financial performance in FY22, total revenue was Rs 8993.85 crore, up 31 per cent from Rs 6862 crore in FY21. Similarly, the net profit for FY22 increased by 50.84 per cent to Rs 2948 crore from Rs 1954 crore in FY21. 

It has consistently been able to produce high ROE and ROCE numbers over the past ten years. As of the FY22 period ending, the company's ROE and ROCE are 28.2 per cent and 35.1 per cent, respectively. 

Regarding the shareholding structure, the promoters own 51.94 per cent of the stake, followed by FIIs with 16.52 per cent, DIIs with 19.98 per cent, and non-institutional investors with 11.56 per cent. 

At 12:14 pm, on August 30, the shares of Divi's Laboratories are trading at Rs 3618.2, up 0.93 per cent on the day. The 52-week high and low for the stock are Rs 5425 and Rs 3365.1, respectively.